ABclonal
Wuhan · Founded 2011
About ABclonal
ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.
Company Facts
- Founded: 2011
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $282.1M
- Funding stage: Late Stage Venture
- Last round: Series D (Dec 2021)
- Website: abclonal.com
- Phone: 888-754-5670
Industries & Categories
Biometrics, Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/abclonal-42961 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.